Neuropsychopharmacology
- Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward1 year ago
- From high-throughput transcriptome characterization of individual synaptosomes to constructing the whole-brain connectome1 year ago
- Repurposing anti-inflammatory medications for alcohol and substance use disorders1 year ago
- High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study1 year ago
- Central amygdala CRF1 cells control nociception and anxiety-like behavior1 year ago
- The parabrachial to central amygdala pathway is critical to injury-induced pain sensitization in mice1 year ago
- Development disturbed: sex-specific transcriptional alterations in adolescent mice after perinatal fentanyl exposure1 year ago
Journal of Psychopharmacology
- The effect of metformin on cognitive function: A systematic review and meta-analysis3 years ago
- Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning3 years ago
- Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)3 years ago
- The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder3 years ago
- Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine3 years ago
- A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults3 years ago
- LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking3 years ago
European Neuropsychopharmacology
- Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)2 years ago
- Early intervention and staging bipolar disorder: Conceptual and clinical dilemmas2 years ago
- Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management2 years ago
- Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”2 years ago
- Comment to “Requiem or resurrection: Classic monoamine oxidase inhibitors revisited”2 years ago
- A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction: A proof-of-concept study2 years ago
- Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study2 years ago